Immunomonitoring of triple negative breast cancer patients undergoing neoadjuvant therapy (GBG89, Geparnuevo trial)

Authors
Category Primary study
JournalAnnals of Oncology
Year 2018
This article has no abstract
Epistemonikos ID: a08fb74a8fcfd3087b1125c8a53bc1dbe8e47fc9
First added on: Feb 11, 2025